Stocks and Investing Stocks and Investing
Fri, November 12, 2021
Thu, November 11, 2021

Paul Knight Maintained (XGN) at Buy with Decreased Target to $30 on, Nov 11th, 2021


Published on 2024-10-27 18:37:56 - WOPRAI, Paul Knight
  Print publication without navigation


Paul Knight of Keybanc, Maintained "Exagen Inc." (XGN) at Buy with Decreased Target from $33 to $30 on, Nov 11th, 2021.

Paul, nor any peers, have made any analyst calls on XGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources